.png)
Agenzia Italiana del Farmaco
home
Highlights
-
23 Nov 2022
Monitoring Registers
Hepatitis C: update of 21 November 2022 concerning enrolled patients
AIFA has published the updated weekly data concerning treatments with new second-generation direct acting antiviral agents (DAAs) for chronic hepatitis C, as collected by AIFA Monitoring registries.
-
18 Nov 2022
Monitoring Registers
Monitoring of antivirals for COVID-19: new report published
The Italian Medicines Agency (AIFA) has published the results of the monitoring of antivirals currently available for treating COVID-19.
-
18 Nov 2022
Information and communication
AIFA publishes Recommendations on targeted therapy of resistant Infections
Aimed at local and hospital medicine to promote optimal use of antibiotics.
-
17 Nov 2022
Information and communication
AIFA initiatives for the World Antimicrobial Awareness Week
Illustrated by AIFA Director General, Nicola Magrini, and Evelina Tacconelli, Professor at the University of Verona, coordinator of the CTS AIFA Opera Working Group
News
23 Nov 2022
Information and communication
AIFA-OECD conference at Luiss on new pharmaceutical development models and preparedness
17 Nov 2022
Monitoring Registers
Monitoring of monoclonal antibodies for COVID-19: weekly report published
15 Nov 2022
Monitoring pharmaceutical expenditure
Monitoring of Pharmaceutical expenditure
15 Nov 2022
Transparency Lists
AIFA updates the Transparency Lists
11 Nov 2022
Safety of medicinal products
EMA confirms measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders
COVID-19
Learn more
FarmaciLine
Questions regarding drug efficacy, safety and availability
TOLL-FREE NUMBER
Interactive OsMed - The use of medicines in Italy
An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology
